Literature DB >> 18606967

Temporal trends in the incidence of multiple sclerosis: a systematic review.

Alvaro Alonso1, Miguel A Hernán.   

Abstract

BACKGROUND: Multiple sclerosis (MS) has been traditionally considered to be more frequent in women and in regions more distant from the equator. However, recent reports suggest that the latitude gradient could be disappearing and that the female-to-male ratio among patients with MS has increased in the last decades. We have conducted a systematic review of incidence studies of MS to assess the overall incidence of MS and explore possible changes in the latitude gradient and the female-to-male ratio over time.
METHODS: Systematic review of incidence studies of MS published in Medline between 1966 and February 2007. Age- and sex-specific incidence rates were collected from eligible publications. We computed age-adjusted rates using the world population as standard, and assessed differences in rates according to latitude and period of case ascertainment. Additionally, we evaluated the association between period of case ascertainment and the female-to-male ratio.
RESULTS: The overall incidence rate of MS was 3.6 cases per 100,000 person-years (95% CI 3.0, 4.2) in women and 2.0 (95% CI 1.5, 2.4) in men. Higher latitude was associated with higher MS incidence, though this latitude gradient was attenuated after 1980, apparently due to increased incidence of MS in lower latitudes. The female-to-male ratio in MS incidence increased over time, from an estimated 1.4 in 1955 to 2.3 in 2000.
CONCLUSION: The latitude gradient present in older incidence studies of multiple sclerosis (MS) is decreasing. The female-to-male MS ratio has increased in the last five decades.

Entities:  

Mesh:

Year:  2008        PMID: 18606967      PMCID: PMC4109189          DOI: 10.1212/01.wnl.0000316802.35974.34

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

1.  Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables.

Authors:  E D ACHESON; C A BACHRACH; F M WRIGHT
Journal:  Acta Psychiatr Scand Suppl       Date:  1960

2.  High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy.

Authors:  Luigi M E Grimaldi; Barbara Palmeri; Giuseppe Salemi; Giuseppe Giglia; Marco D'Amelio; Roberto Grimaldi; Gaetano Vitello; Paolo Ragonese; Giovanni Savettieri
Journal:  Neuroepidemiology       Date:  2006-12-08       Impact factor: 3.282

Review 3.  MS in Asian countries.

Authors:  M Wasay; I A Khatri; B Khealani; M Sheerani
Journal:  Int MS J       Date:  2006-05

Review 4.  Environmental risk factors for multiple sclerosis. Part I: the role of infection.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

5.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.

Authors:  Kassandra L Munger; Lynn I Levin; Bruce W Hollis; Noel S Howard; Alberto Ascherio
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

Review 6.  The epidemiology of multiple sclerosis in Europe.

Authors:  M Pugliatti; G Rosati; H Carton; T Riise; J Drulovic; L Vécsei; I Milanov
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

7.  Possible increasing risk of multiple sclerosis in Catania, Sicily.

Authors:  A Nicoletti; F Patti; S Lo Fermo; V Sorbello; E Reggio; D Maimone; M Zappia; A Reggio
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

8.  How common are the "common" neurologic disorders?

Authors:  D Hirtz; D J Thurman; K Gwinn-Hardy; M Mohamed; A R Chaudhuri; R Zalutsky
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

9.  Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain.

Authors:  Y Aladro; M J Alemany; M C Pérez-Vieitez; R Amela; M Conde; M P Reyes; F Alamo; A Angel-Moreno
Journal:  Neuroepidemiology       Date:  2004-09-24       Impact factor: 3.282

10.  Sex ratio of multiple sclerosis in Canada: a longitudinal study.

Authors:  Sarah-Michelle Orton; Blanca M Herrera; Irene M Yee; William Valdar; Sreeram V Ramagopalan; A Dessa Sadovnick; George C Ebers
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

View more
  158 in total

Review 1.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

Review 2.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

3.  Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors.

Authors:  Joshua A Cohn; Shenghua Ni; Melissa R Kaufman; Amy J Graves; David F Penson; Roger R Dmochowski; W Stuart Reynolds
Journal:  Neurourol Urodyn       Date:  2017-03-07       Impact factor: 2.696

4.  Catastrophizing, pain, and pain interference in individuals with disabilities.

Authors:  Adam T Hirsh; Tamara B Bockow; Mark P Jensen
Journal:  Am J Phys Med Rehabil       Date:  2011-09       Impact factor: 2.159

Review 5.  Cognitive Assessment of Individuals with Multiple Sclerosis in the Arab World: a Systematic Review.

Authors:  Samira Paul; Aeysha Brown; Abbey J Hughes
Journal:  Neuropsychol Rev       Date:  2019-05-17       Impact factor: 7.444

6.  Are the prevalence and incidence of multiple sclerosis changing?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

Review 7.  Neuroimaging in multiple sclerosis: neurotherapeutic implications.

Authors:  Nancy L Sicotte
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

8.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

Review 9.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

10.  The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?

Authors:  Eric C Klawiter; Anne H Cross; Robert T Naismith
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.